Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1269476 | 0.83 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL8629351 | 0.80 | ALDH1A1 (0.42) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL7164891 | 0.71 | CYP2D6 (0.33) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL23485766 | 0.69 | ALDH1A1 (0.42) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL21450453 | 0.69 | ALDH1A1 (0.42) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL4950743 | 0.69 | LMNA (0.43) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL28393846 | 0.68 | ALDH1A1 (0.37) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL2516387 | 0.68 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL2513933 | 0.68 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL2128266 | 0.68 | LMNA (0.39) | ALDH1A1PKMSLC1A2LMNACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4388014-A1 | MULTIVALENT ANTI-VARIANT FC-REGION ANTIBODIES AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2024-06-26 | — | — | EP | claimed |
| CN-117858905-A | Multivalent anti-variant FC region antibodies and methods of use | 豪夫迈·罗氏有限公司 | 2024-04-09 | — | — | CN | claimed |
| WO-2023021055-A1 | MULTIVALENT ANTI-VARIANT FC-REGION ANTIBODIES AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2023-02-23 | — | — | WO | claimed |
| EP-4388014-A1 | MULTIVALENT ANTI-VARIANT FC-REGION ANTIBODIES AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2024-06-26 | — | — | EP | disclosed |
| CN-117858905-A | Multivalent anti-variant FC region antibodies and methods of use | 豪夫迈·罗氏有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-116196434-A | Antibody-drug conjugate, preparation method and application thereof | 苏州泽璟生物制药股份有限公司 | 2023-06-02 | — | — | CN | disclosed |
| WO-2023021055-A1 | MULTIVALENT ANTI-VARIANT FC-REGION ANTIBODIES AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2023-02-23 | — | — | WO | disclosed |
| US-9933433-B2 | Anti-drug antibody assay | HOFFMANN-LA ROCHE INC. (US) | 2018-04-03 | — | — | US | disclosed |
| EP-2089434-B1 | ANTI-IDIOTYPE CONJUGATE AND ITS USE AS A STANDARD IN AN IMMUNASSAY | HOFFMANN LA ROCHE (CH) | 2015-12-30 | — | — | EP | disclosed |
| US-20140349323-A1 | ANTI-DRUG ANTIBODY ASSAY | F. HOFFMANN-LA ROCHE AG (CH) | 2014-11-27 | — | — | US | disclosed |
| US-8809005-B2 | Conjugate and its use as a standard in an immunoassay | HOFFMANN-LA ROCHE INC. (US) | 2014-08-19 | — | — | US | disclosed |
| WO-2008031532-A1 | ANTI-DRUG ANTIBODY ASSAY | F. HOFFMANN-LA ROCHE AG (CH) | 2008-03-20 | — | — | WO | disclosed |
| EP-0685070-B1 | ACYLATED PROTEIN AGGREGATES AND THEIR USE IN SUPPRESSING INTERFERENCE IN IMMUNOASSAYS | ROCHE DIAGNOSTICS GMBH (DE) | 2003-09-03 | — | — | EP | disclosed |
| EP-0684956-B1 | ACYLATED PROTEIN AGGREGATES AND THEIR USE IN ENHANCING SIGNALS IN AN IMMUNOASSAY TESTING FOR ANTIBODIES | ROCHE DIAGNOSTICS GMBH (DE) | 2003-07-16 | — | — | EP | disclosed |
| US-5998157-A | CONTACTING SAMPLE WITH ANTIBODY AND BINDING PARTNER IN PRESENCE OF ACYLATED PROTEIN AGGREGATE | ROCHE DIAGNOSTICS GMBH (DE) | 1999-12-07 | — | — | US | disclosed |
| US-5658725-A | REDUCING NON-SPECIFIC INTERACTIONS | BOEHRINGER MANNHEIM GMBH (DE) | 1997-08-19 | — | — | US | disclosed |
| EP-0685070-A1 | ACYLATED PROTEIN AGGREGATES AND THEIR USE IN SUPPRESSING INTERFERENCE IN IMMUNOASSAYS | Roche Diagnostics GmbH (DE) | 1995-12-06 | — | — | EP | disclosed |
| EP-0684956-A1 | ACYLATED PROTEIN AGGREGATES AND THEIR USE IN ENHANCING SIGNALS IN AN IMMUNOASSAY TESTING FOR ANTIBODIES | Roche Diagnostics GmbH (DE) | 1995-12-06 | — | — | EP | disclosed |
| WO-1995017427-A1 | ACYLATED PROTEIN AGGREGATES AND THEIR USE IN ENHANCING SIGNALS IN AN IMMUNOASSAY TESTING FOR ANTIBODIES | BOEHRINGER MANNHEIM GMBH (DE) | 1995-06-29 | — | — | WO | disclosed |
| WO-1995017668-A1 | ACYLATED PROTEIN AGGREGATES AND THEIR USE IN SUPPRESSING INTERFERENCE IN IMMUNOASSAYS | BOEHRINGER MANNHEIM GMBH (DE) | 1995-06-29 | — | — | WO | disclosed |